These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27744704)

  • 41. Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine.
    Zhang Z; Liu Z; Ma L; Jiang S; Wang Y; Yu H; Yin Q; Cui J; Li Y
    Mol Pharm; 2013 Jun; 10(6):2426-34. PubMed ID: 23679827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X; Chang Z; Song J; Gao G; Shen Z
    Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.
    Jin J; Sun H; Wei H; Liu G
    Invest New Drugs; 2007 Apr; 25(2):95-105. PubMed ID: 16937080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
    Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
    Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poly(styrene oxide)-poly(ethylene oxide) block copolymers: From "classical" chemotherapeutic nanocarriers to active cell-response inducers.
    Cambón A; Rey-Rico A; Barbosa S; Soltero JF; Yeates SG; Brea J; Loza MI; Alvarez-Lorenzo C; Concheiro A; Taboada P; Mosquera V
    J Control Release; 2013 Apr; 167(1):68-75. PubMed ID: 23352909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluplus(®) micelles as a potential drug delivery system for reversal of resistant tumor.
    Jin X; Zhou B; Xue L; San W
    Biomed Pharmacother; 2015 Feb; 69():388-95. PubMed ID: 25661387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
    Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
    Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
    Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D
    Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanomicelles based on X-shaped four-armed peglyated distearylglycerol as long circulating system for doxorubicin delivery.
    Zhang W; Sun J; Fang W; Ai X; Cai C; Tang Y; Su X; Feng Z; Liu Y; Tao M; Yan X; Chen G; He Z
    Eur J Pharm Sci; 2015 Jan; 66():96-106. PubMed ID: 25446512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
    Ji W; Wang B; Fan Q; Xu C; He Y; Chen Y
    PLoS One; 2017; 12(7):e0180037. PubMed ID: 28686704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells.
    Xue P; Yang X; Liu Y; Xiong C; Ruan J
    Biomed Pharmacother; 2014 Oct; 68(8):1049-56. PubMed ID: 25455158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-delivery of docetaxel and verapamil by reduction-sensitive PEG-PLGA-SS-DTX conjugate micelles to reverse the multi-drug resistance of breast cancer.
    Guo Y; He W; Yang S; Zhao D; Li Z; Luan Y
    Colloids Surf B Biointerfaces; 2017 Mar; 151():119-127. PubMed ID: 27988472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The novel bis-benzylisoquinoline PY35 reverses P-glycoprotein-mediated multidrug resistance.
    Cao Z; Wright M; Cheng J; Huang X; Liu L; Wu L; Yang P
    Oncol Rep; 2014 Sep; 32(3):1211-7. PubMed ID: 25017650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondria-targeted vitamin E succinate delivery for reversal of multidrug resistance.
    Liang L; Peng Y; Qiu L
    J Control Release; 2021 Sep; 337():117-131. PubMed ID: 34274383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doxorubicin-loaded micelles of reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) block copolymers as efficient "active" chemotherapeutic agents.
    Cambón A; Rey-Rico A; Mistry D; Brea J; Loza MI; Attwood D; Barbosa S; Alvarez-Lorenzo C; Concheiro A; Taboada P; Mosquera V
    Int J Pharm; 2013 Mar; 445(1-2):47-57. PubMed ID: 23380628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.